PI3Kα/HDAC6-IN-1
Product Specifications
UNSPSC Description
PI3Kα/HDAC6-IN-1 (compound 21j) is a dual PI3Kα/HDAC6 inhibitor with IC50 of 2.9 and 26 nM, respectively. PI3Kα/HDAC6-IN-1 also inhibits AKT(Ser473) phosphorylation and induces the accumulation of acetylated α-tubulin without affecting acetylated histones H3 and H4. PI3Kα/HDAC6-IN-1 efficiently inhibits L-363 cell line (IC50=0.17 μM) and has good anti-cancer activity[1].
Target Antigen
HDAC; PI3K
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics;PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/pi3kα-hdac6-in-1.html
Solubility
10 mM in DMSO
Smiles
CC(C(F)(F)F)(C)C1=CC(C2=C(C)N=C(NC(N3C[C@H](NS(=O)(CC4=CC=C(C(NO)=O)C=C4)=O)C[C@H]3C(N)=O)=O)S2)=CC=N1
Molecular Weight
669.70
References & Citations
[1]Zhang Y, et al. Discovery of (S)-N1-(thiazol-2-yl) pyrrolidine-1,2-dicarboxamide derivatives targeting PI3Ka/HDAC6 for the treatment of cancer. Bioorg Med Chem Lett. 2023 Oct 1;94:129462.. .
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156091/PI3Kα-HDAC6-IN-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156091/
Clinical Information
No Development Reported
CAS Number
3007565-26-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx346764-01 50 µL
Cardiac-enriched FHL2-interacting protein (CEFIP) Antibody (FITC)
Ask
View Details 
abx346764-02 100 µL
Cardiac-enriched FHL2-interacting protein (CEFIP) Antibody (FITC)
Ask
View Details 
abx346764-03 200 µL
Cardiac-enriched FHL2-interacting protein (CEFIP) Antibody (FITC)
Ask
View Details 
abx346764-04 1 mL
Cardiac-enriched FHL2-interacting protein (CEFIP) Antibody (FITC)
Ask
View Details 
BNC681812-500 500 µL
Anti-MART-1 / Melan-A / MLANA (Melanoma Marker) (rMLANA/788), CF568 conjugate
Ask
View Details